Randomized Trialhigh evidence
Sugammadex for Reversal of Neuromuscular Blockade in Neonates and Infants Less than 2 Years Old: Results from a Phase IV Randomized Clinical Trial.
Anesthesiology·August 1, 2025·PMID 40324166
Why it mattersSugammadex is widely used in older children and adults, but data in neonates and infants under 2 years are limited. This trial provides robust evidence for its efficacy and safety in this vulnerable population, supporting more predictable and rapid neuromuscular recovery.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled